TGFB1 and heavy chain disease: In HCD group, the expression levels of TGF-β (Figure 4(a)), Smad-2 (Figure 4(b)), and Smad-4 (Figure 4(c)) were significantly increased by 8-, 8.5-, and 5.3-fold, compared to the control group.